In a 90 minute meeting with HIV advocates and implementers today, Ann Gavaghan spent almost as much time explaining what PEPFAR’s new five-year strategy does not mean as what it does mean. The term “increased efficiencies” is not some code for budget cuts, Gavaghan promised, but rather a mandate to maximize the impact of PEPFAR […]
HIV
The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. […]
Tuberculosis
The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
Haiti already faced a daunting path to recovery in the wake of the catastrophic 2010 earthquake that destroyed much of its capital city, with devastating damage […]